ATE350101T1 - Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens - Google Patents

Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens

Info

Publication number
ATE350101T1
ATE350101T1 AT02743320T AT02743320T ATE350101T1 AT E350101 T1 ATE350101 T1 AT E350101T1 AT 02743320 T AT02743320 T AT 02743320T AT 02743320 T AT02743320 T AT 02743320T AT E350101 T1 ATE350101 T1 AT E350101T1
Authority
AT
Austria
Prior art keywords
heart failure
congestive heart
treatment
pyridazinone derivative
mammal
Prior art date
Application number
AT02743320T
Other languages
English (en)
Inventor
Heimo Haikala
Esa-Pekka Sandell
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE350101T1 publication Critical patent/ATE350101T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02743320T 2001-07-04 2002-07-04 Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens ATE350101T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20011465A FI20011465A0 (fi) 2001-07-04 2001-07-04 Pyridatsinonijohdannaisen uusi käyttö

Publications (1)

Publication Number Publication Date
ATE350101T1 true ATE350101T1 (de) 2007-01-15

Family

ID=8561590

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02743320T ATE350101T1 (de) 2001-07-04 2002-07-04 Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens

Country Status (9)

Country Link
US (1) US20040180895A1 (de)
EP (1) EP1401450B1 (de)
JP (1) JP2004535457A (de)
AT (1) ATE350101T1 (de)
CA (1) CA2450821A1 (de)
DE (1) DE60217336T2 (de)
ES (1) ES2278930T3 (de)
FI (1) FI20011465A0 (de)
WO (1) WO2003004035A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
MX2017004842A (es) * 2014-10-15 2017-06-22 Orion Corp Levosimendan para uso en el tratamiento de enfermedades de las neuronas motoras (por ejemplo esclerosis lateral amiotrofica).
EP3993773A1 (de) 2019-07-01 2022-05-11 Orion Corporation Verfahren zur verabreichung (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamid
US11969424B2 (en) 2019-12-16 2024-04-30 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
US4517310A (en) * 1981-07-28 1985-05-14 Berlex Laboratories, Inc. N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butanamine and use thereof as a cardiotonic agent
US4432979A (en) * 1981-10-26 1984-02-21 William H. Rorer, Inc. Pyridone compounds
JP3131845B2 (ja) * 1991-06-12 2001-02-05 帝国臓器製薬株式会社 慢性心不全治療剤
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
US5905078A (en) * 1998-06-19 1999-05-18 Orion Corporation Use of a pyridazinone derivative
FI20011464A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Yhdistelmäterapia sydämen vajaatoiminnan hoitoon

Also Published As

Publication number Publication date
DE60217336D1 (de) 2007-02-15
US20040180895A1 (en) 2004-09-16
CA2450821A1 (en) 2003-01-16
WO2003004035A1 (en) 2003-01-16
DE60217336T2 (de) 2007-10-04
EP1401450B1 (de) 2007-01-03
ES2278930T3 (es) 2007-08-16
JP2004535457A (ja) 2004-11-25
EP1401450A1 (de) 2004-03-31
FI20011465A0 (fi) 2001-07-04

Similar Documents

Publication Publication Date Title
IS8058A (is) Sýklísk súlfónamíð til að hamla gamma seytiasa
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
DE602006013883D1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen
MX2007004041A (es) Fenilpirazoles.
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
NO992282L (no) Benzonaftyridiner som bronkialterapentika
NO20065079L (no) Materialer og metoder for behandling av koaguleringssykdommer
NO970164D0 (no) Anvendelse av tiazol- og tiadiazolforbindelser som D3 - dopaminreseptorligander
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
DE60127537D1 (de) VERWENDUNG VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLOÄ1,5-bÜPYRIDAZINE ZUR BEHANDLUNG VON NICHTULZERATIVER DYSPEPSIE
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
ATE429916T1 (de) Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
ATE350101T1 (de) Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens
IL140032A0 (en) New use of a pyridazinone derivative
ES2097025T3 (es) Oxindol 1-(n-(alcoxicarbonil))carboxamidas y 1-(n-carboxamido)carboxamidas como agentes antiinflamatorios.
MA27812A1 (fr) Utilisation d'un inhibiteur de tyrosine kinase c-abl, pdgf-r ou c-kit dans le traitement du diabete
EA200500242A1 (ru) Пиперидин-2,5-дионовые памоатные соли и их использование для лечения связанных со стрессом аффективных расстройств
DE60318089D1 (de) Protein-tyrosine-kinase-inhibitoren
BR0312242A (pt) 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il) pirimidin-2-ilamino)fenil]-benzamida para o tratamento da fibrose pulmonar
DE60122171D1 (de) Verwendung von substituierten pyrazolen zur herstellung eines medikaments zur behandlung von allergien
DE60305460D1 (de) Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen
DE60216441D1 (de) Mittel zur verbesserung der gewebepenetration

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties